Physician at the Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation On the topic: What are clinical trials? Head and neck studies on the study platform of the CCC
direction by ELN David Chairs Michael Heuser Dept. of Hematology, Hemostatis, Oncology and Stem Cell Transplant., Hanover Medical School, Germany Jacqueline Cloos Dept. of Hematology, VU University Medical Center
Weyand, M., and Forster, R. (2008). Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3. Transplantation 86 , 590-600. Forster, R., Davalos-Misslitz [...] Prinz I**, Koenecke C**. Focusing of the regulatory T cell repertoire after allogeneic stem cell transplantation indicates protection from graft-versus-host disease. Haematologica. 2019 Apr 24. pii: haematol [...] Förster R, Koenecke C, Prinz I. Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat Immunol. 2017 Feb 20.
von Kaisenberg C, Schambach A, Buettner FFR, Janciauskiene S, Lachmann N, Moritz T. "Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT [...] T, Schambach A. "Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants" J Pers Med . 2021 Jun 17;11(6):565. doi: 10.3390/jpm11060565. Dannenmann B, Klimiankou M, Oswald [...] Lachmann N, Moritz T, Trapnell BC. "Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra-/- Mice. Mol Ther. 2019 Sep 4;27(9):1597-1611 Hetzel M, Lopez-Rodriguez
took on administrative tasks in the Clinical Department for Hematology, Oncology and Stem Cell Transplantation. This dual function came about because the Tumor Center was part of the Clinical Department until
to combat HEV infections Mara Klöhn (Bochum) 13:15-13:35 Risk factors for hepatitis E in kidney transplant recipients Mira Choi (Berlin) 13:40-14:30 Roundtable Discussion II Clinical Management of HEV –
leader: Prof. Dr. Britta Eiz-Vesper Department / Institute: Institute of Transfusion Medicine and Transplant Engineering (ITT) In well-characterized large cohorts of actively infected and recovered COVID-19
(online) You will find the programme and the registration link here shortly. 23.09.2026 | Liver Transplant Oncology (online) Scientific management: Prof. Dr. med. Heiner Wedemeyer Scientific organization:
Walter / PD Dr. Martin Schlaud) Harries, Lena: Care structures in transplantation - Analysis of care pathways and costs of liver transplant patients (Prof. Dr. Volker Amelung / PD Dr. Harald Schrem) Langhof
and the Experimental Laboratory on the topics of the intensive care unit, pain board and organ transplantation. The German Academy of Neurosurgery promotes the academic development of neurosurgery in Germany